Omron Corp. (OTCMKTS:OMRNY) Short Interest Down 30.5% in March

Omron Corp. (OTCMKTS:OMRNY) saw a large drop in short interest in the month of March. As of March 13th, there was short interest totaling 19,212 shares, a drop of 30.5% from the February 26th total of 27,640 shares. Based on an average trading volume of 87,248 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the company’s shares are sold short.

Institutional Investors Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC grew its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the quarter. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Omron Stock Performance

OTCMKTS:OMRNY opened at $26.95 on Monday. Omron has a 12-month low of $23.23 and a 12-month high of $35.90. The firm has a market cap of $5.56 billion, a PE ratio of 34.11, a price-to-earnings-growth ratio of 0.42 and a beta of 0.92. The company has a current ratio of 2.11, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. The stock has a fifty day moving average price of $29.30 and a 200 day moving average price of $27.54.

Omron (OTCMKTS:OMRNY) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.19). The company had revenue of $1.41 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Sell-side analysts anticipate that Omron will post 0.42 earnings per share for the current fiscal year.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.